Aprinoia Therapeutics

Aprinoia Therapeutics is a company that discovers and develops diagnostics and therapeutics for Alzheimer’s Disease and other tau-associated neurodegenerative diseases (Tauopathies). It achieves its mission by building comprehensive internal drug discovery and development capabilities and integrative collaborations with scientists, research institutions and pharmaceutical companies, to bring innovative ideas and scientific discoveries to life.

The company is committed to establishing a drug discovery and early-stage development company that is based on innovation, scientific rigor and integrity. Its goal is to develop novel products to address significant patients' needs, including: Novel imaging-based diagnostic tools to enhance the detection of occurrence, progression, and regression of neurological diseases; and Novel therapies to enhance the treatment of human neurological conditions.